- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
International Journal of Alzheimer's Disease
Volume 2012 (2012), Article ID 251426, 13 pages
Protein Tau: Prime Cause of Synaptic and Neuronal Degeneration in Alzheimer's Disease
Experimental Genetics Group (LEGTEGG), Department of Human Genetics, KU Leuven, Campus Gasthuisberg ON1-06.602, Herestraat 49, 3000 Leuven, Belgium
Received 14 February 2012; Accepted 16 March 2012
Academic Editor: Rakez Kayed
Copyright © 2012 Natalia Crespo-Biel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [6 citations]
The following is the list of published articles that have cited the current article.
- Qiu-Yan Liu, Jin-Tai Yu, Dan Miao, Xiao-Ying Ma, Hui-Fu Wang, Wei Wang, and Lan Tan, “An exploratory study on STX6, MOBP, MAPT, and EIF2AK3 and late-onset Alzheimer's disease,” Neurobiology of Aging, vol. 34, no. 5, pp. 1519.e13–1519.e17, 2013.
- Wenjia Lai, Jing Wu, Xiao Zou, Jian Xie, Liwei Zhang, Xuyang Zhao, Minzhi Zhao, Qingsong Wang, and Jianguo Ji, “Secretome Analyses of A beta(1-42) Stimulated Hippocampal Astrocytes Reveal that CXCL10 is Involved in Astrocyte Migration,” Journal of Proteome Research, vol. 12, no. 2, pp. 832–843, 2013.
- Manjinder Singh, Maninder Kaur, Hitesh Kukreja, Rajan Chugh, Om Silakari, and Dhandeep Singh, “Acetylcholinestrase Inhibitors as Alzheimer Therapy: From Nerve Toxins to Neuroprotection,” European Journal of Medicinal Chemistry, 2013.
- Chandishwar Nath, and Shivika Rai, “Okadaic acid induced neurotoxicity: An emerging tool to study Alzheimer's d isease pathology,” Neurotoxicology, vol. 37, pp. 163–172, 2013.
- Benoît Leclerc, and Abedelnasser Abulrob, “Perspectives in Molecular Imaging Using Staging Biomarkers and Immunotherapies in Alzheimer’s Disease,” The Scientific World Journal, vol. 2013, pp. 1–16, 2013.
- Wolfgang Froestl, Andrea Pfeifer, and Andreas Muhs, “Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets ot her than Receptors or Enzymes. Disease-modifying Drugs,” Journal of Alzheimers Disease, vol. 34, no. 1, pp. 1–114, 2013.